Topics
-
Our Response to the Coronavirus Disease 2019
-
Sysmex Awarded the "Prime" Status by ISS ESG Corporate Rating
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fifth Consecutive Year
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
-
Sysmex Receives “Minister of Education, Culture, Sports, Science and Technology Prize”, and three other awards in 2020 “Kinki Local Commendation for Inventions”
-
Business Results Announcement for the Fiscal Year Ending March 31, 2021 (See Latest Financial Statements)
Press Releases
-
Kobe University and Sysmex Conducted Clinical Evaluation of the ELISPOT Method: A New Test for COVID-19 using blood
- Report on T cell Immunity to SARS-CoV-2 in the Japanese Population - (PDF：561KB) - Sysmex Obtains Marketing Approval for the HISCL™ IFN-λ3 Assay Kit, a Test Kit to Assist in Determining Exacerbation Risk in Novel Coronavirus (SARS-CoV-2)-Positive Patients (PDF：172KB)
- Sysmex Launches Surgical Robot Unit, hinotori™ Surgical Robot System (PDF：154KB)
-
Sysmex Obtains Manufacturing and Marketing Approval for a SARS-CoV-2 Antigen Detection Reagent
- Detecting SARS-CoV-2 Antigens Using Fully Automated Immunoassay Systems HISCL™-5000 / HISCL™-800 - (PDF：170KB) -
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
- The Content Presented at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference - (PDF：182KB)
